LGND vs PTCT: stock comparison and AI forecast
Ligand Pharmaceuticals Inc (LGND) and Ptc Therapeutics, Inc. (PTCT) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
LGND Ligand Pharmaceuticals Inc
- Price
- $313.52 +35.0% · 6M
- Market Cap
- $6.27B
- P/E Ratio
- 119.7x
- Size
- mid-cap
- AI Forecast
PTCT Ptc Therapeutics, Inc.
- Price
- $68.12 +4.7% · 6M
- Market Cap
- $5.69B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- LGND is 1.1 times larger than PTCT by market capitalization ($6.27B against $5.69B).
- Over the last six months LGND returned +35.0% and PTCT +4.7%.
- LGND turns 14.8% of its revenue into net income, against -9.2% for PTCT.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | LGND | PTCT |
|---|---|---|
| Market Cap | $6.27B | $5.69B |
| P/E Ratio | 119.68x | – |
| P/B Ratio | 6.52x | – |
| EPS | $2.62 | $-2.25 |
| Book Value/Share | $48.08 | – |
| Revenue/Share | $17.34 | $13.83 |
| FCF/Share | $4.53 | $0.02 |
Profitability & Margins
| Metric | LGND | PTCT |
|---|---|---|
| ROE | 5.3% | – |
| ROA | 2.3% | -3.3% |
| ROIC | 1.4% | 6.1% |
| Operating Margin | 6.9% | 12.8% |
| Net Margin | 14.8% | -9.2% |
| EBT Margin | 15.2% | -7.4% |
| Tax Rate | 2.4% | -24.5% |
Financial Health
| Metric | LGND | PTCT |
|---|---|---|
| Current Ratio | 1.22x | 3.27x |
| Quick Ratio | 1.19x | 3.13x |
| D/E Ratio | 1.33x | – |
| Financial Leverage | 2.33x | – |
| Interest Coverage | – | 7.3x |
| Working Capital | $108M | $1.76B |
Cash Flow
| Metric | LGND | PTCT |
|---|---|---|
| Operating Cash Flow | $91M | $10M |
| Free Cash Flow | $91M | $2M |
| Capital Spending | -$410K | -$8M |
| OCF Growth YoY | 185.2% | -98.5% |
| FCF Growth YoY | 194.6% | -99.7% |
| FCF/Sales | 26.1% | 0.2% |
| CapEx/Sales | 0.1% | 0.7% |
Operational Efficiency
| Metric | LGND | PTCT |
|---|---|---|
| Asset Turnover | 0.15x | 0.36x |
| Receivables Turnover | 4.2x | 4.8x |
| Fixed Assets Turnover | 93.5x | 23.4x |
| Days Sales Outstanding | 88 days | 75 days |
Income Statement
| Metric | LGND | PTCT |
|---|---|---|
| Total Revenue | $347M | $1.16B |
| Operating Income | $24M | $148M |
| Net Income | $51M | -$106M |
| R&D Expense | $23M | $438M |
| SG&A Expense | – | $344M |
Dividend & Shareholder Information
| Metric | LGND | PTCT |
|---|---|---|
| Shares Outstanding | 20M | 84M |
| Net Income Growth | 5.9% | -114.1% |
| EPS Growth | 30.4% | -126.3% |
LGND vs PTCT: stock comparison and AI forecast
Which is bigger, LGND or PTCT?
LGND is 1.1 times larger than PTCT by market capitalization ($6.27B against $5.69B).
Which stock performed better over the last six months, LGND or PTCT?
Over the last six months LGND returned +35.0% and PTCT +4.7%.
Which one does Intratio's AI model rank higher, LGND or PTCT?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.